Despite a market bloodbath that left the S&P 500 down 4.84%, Vertex Pharmaceuticals managed a modest gain of 0.11%, flaunting resilience. The biotech firm outpaced the broader medical sector over the ...

Wells Fargo analyst Mohit Bansal maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price target ...

Vertex Pharmaceuticals has analysts doing financial backflips as they boost its price targets, with Royal Bank of Canada ...

HHS had argued that Vertex's plan to cover fertility services for some patients that took its gene therapy would violate anti-kickback and inducement laws.

Vertex is ending work on one of its two clinical-stage islet cell treatments after the diabetes therapy looked unlikely to ...

Vertex Minerals Ltd. is pleased to announce that its Ordinary Shares have been approved to trade on the OTCQB Venture Market in the United States of America and have commenced trading under the ticker ...

If you’re on the fence about investing in Elastic N.V., Vertex or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your decision. Read on ...

W-2 forms should have arrived in mailboxes and inboxes by Jan. 31. Here's what to do if you haven't gotten yours yet. Macy Meyer Writer II Macy Meyer is a North Carolina native who graduated from ...

Vertex Pharmaceuticals has a 1 year low of $377.85 and a 1 year high of $519.88. The stock’s 50 day simple moving average is $464.06 and its 200-day simple moving average is $462.31.

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $512.52, indicating a +0.06% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 1. ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best diabetes stocks to buy according to billionaires. The WHO ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best high growth stocks to invest in. After two years of 25%+ gains ...